Successes and challenges of China's health care reform: a four-decade perspective spanning 1985-2023
- PMID: 37649062
- PMCID: PMC10469830
- DOI: 10.1186/s12962-023-00461-9
Successes and challenges of China's health care reform: a four-decade perspective spanning 1985-2023
Abstract
Chinese health system remains the crucial one for understanding the wider healthcare landscape across the Global South and in particular the leading Emerging Markets. Purpose of our observation was to understand the inner dynamics of mainland Chinese health reforms adopting a lengthy time horizon. We have analysed the public reports and seminal evidence on Chinese of multiple waves of national health reforms taking place since 1980s in terms of medical care and pharmaceuticals provision and financing. Chinese international trade with ASEAN nations and wider South-East Asia is accelerating its growth after the recovery of trade routes. In terms of health sector this means that global demand and supply of medical goods, services and pharmaceuticals remains largely driven by Chinese domestic developments. Furthermore, Chinese domestic manufacturing and sales of decent quality medical devices and services have grown exponentially. Some temporary pitfalls and increasing in rural-urban inequalities in equity of access and affordability of medical care and pharmaceuticals did take place. Despite these difficulties to generate a balanced development strategy for the largest global market, this is a clear path upwards. Further upcoming improvements expanding health insurance coverage are in strong demand for certain layers of the society. Domestic bottleneck weaknesses yet remain manufacturing, import and market penetration of cutting-edge pharmaceuticals such as monoclonal antibodies and targeted oncology agents. Yet some of these obstacles are likely to be overcome in foreseeable future with the adoption of responsible strategies by governmental agencies in health care arena.
Keywords: Chinese health reform; Demand; Industry; Insurance policy; Manufacturing; Market; Medical care; Medical devices; Perspective; Pharmaceuticals; Standards; Supply.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare that Mihajlo Jakovljevic is Editor-in-Chief of the journal, and they declare no conflict of interest. The funding agency had no role in designing the study, conducting the analysis, interpreting the data or writing the manuscript.
Figures
Similar articles
-
The Global South political economy of health financing and spending landscape - history and presence.J Med Econ. 2021 Nov;24(sup1):25-33. doi: 10.1080/13696998.2021.2007691. J Med Econ. 2021. PMID: 34866543 Review.
-
The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.BMC Health Serv Res. 2022 Sep 22;22(1):1189. doi: 10.1186/s12913-022-08574-2. BMC Health Serv Res. 2022. PMID: 36138390 Free PMC article.
-
Managing the health care market in developing countries: prospects and problems.Health Policy Plan. 1994 Sep;9(3):237-51. doi: 10.1093/heapol/9.3.237. Health Policy Plan. 1994. PMID: 10137740 Review.
-
Asian innovation in pharmaceutical and medical device industry - beyond tomorrow.J Med Econ. 2021 Nov;24(sup1):42-50. doi: 10.1080/13696998.2021.2013675. J Med Econ. 2021. PMID: 34915798
-
Constructing healthcare services markets: networks, brokers and the China-England engagement.Global Health. 2022 Dec 9;18(1):102. doi: 10.1186/s12992-022-00892-8. Global Health. 2022. PMID: 36494851 Free PMC article.
Cited by
-
Random forest model used to predict the medical out-of-pocket costs of hypertensive patients.Front Public Health. 2024 Jul 17;12:1382354. doi: 10.3389/fpubh.2024.1382354. eCollection 2024. Front Public Health. 2024. PMID: 39086805 Free PMC article.
-
Off-label drug use in China after the Physician Law (2021): legal challenges and solutions.Front Pharmacol. 2025 Apr 14;16:1547418. doi: 10.3389/fphar.2025.1547418. eCollection 2025. Front Pharmacol. 2025. PMID: 40297142 Free PMC article.
-
The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.Heart Fail Rev. 2024 Mar;29(2):405-416. doi: 10.1007/s10741-023-10362-x. Epub 2023 Oct 23. Heart Fail Rev. 2024. PMID: 37870703
-
Studying an educational intervention and its impact on health-related quality of life and fasting blood glucose levels among patients with type 2 diabetes mellitus in rural China.BMC Health Serv Res. 2025 Jul 2;25(1):884. doi: 10.1186/s12913-025-13075-z. BMC Health Serv Res. 2025. PMID: 40604789 Free PMC article.
-
Health Hazard Among Shrimp Cultivators in India: A Quantitative Burden of Disease Study.Int J Gen Med. 2024 Mar 21;17:1101-1116. doi: 10.2147/IJGM.S449364. eCollection 2024. Int J Gen Med. 2024. PMID: 38529100 Free PMC article.
References
-
- Meyer N, Meyer DF. An econometric analysis of entrepreneurial activity, economic growth and employment: The case of the BRICS countries.
-
- Li L, Liu S, Li C, Zhang P, Lo K. What matters for regional economic resilience amid multi shock situations: structural or agency? Evidence from resource-based cities in China. Sustainability. 2022;14(9):5701. doi: 10.3390/su14095701. - DOI
Publication types
LinkOut - more resources
Full Text Sources